2024-11-06T00:00:00-0500

2024-11-07T00:00:00-0500

Private Equity Boston Forum Boston | November 6-7, 2024 Request Agenda


The Private Equity Boston Forum is the leading East Coast investor-centric event for LPs investing in private markets.

The forum brings together investors, fund managers, and advisers for a two-day meeting to discuss sectors, due diligence, and private equity investment opportunities in The US and around the world.

The investor-focused event provides a due diligence forum for pension funds, foundations, endowments, funds of funds, family offices, wealth managers, consultants, and sovereign wealth funds interested in direct research on private investment opportunities.

Session topics cover the entire spectrum of private equity investments, from sector-specific sessions to discussions on global buyout opportunities and roundtables of leading global institutional investors discussing their specific investment appetites.


banner


KEYNOTE SPEAKERS

John Maldonado, Managing Partner, Advent International

John Maldonado joined Advent in 2006 focusing on buyouts in the healthcare, financial and business services sectors. His previous private equity experience includes positions at both Bain Capital and Parthenon Capital. John began his career as a Consultant with The Par-thenon Group, a leading strategy consulting firm. John earned a BA, summa cum laude, from Dartmouth College and an MBA, with high distinction, as a Baker Scholar from Harvard Business School. During his career, John has worked on 27 investments, 22 during his time at Advent, including Bharat Serums and Vaccines, Cotiviti, Definitive Healthcare, Genoa Healthcare, Iodine Software, Simtra BioPharma Solutions, and Suven Pharmaceuticals.

Chris Gaffney, Co-Founder and Managing Director, Great Hill Partners

Chris Gaffney is Co-Founder and Managing Director of Great Hill Partners, where he is responsible for investment policy, investor relations and the general management of the firm. Chris is also a member of the firm’s executive and investment committees. Throughout the course of his over 37-year career in private equity, Chris has participated in investments covering a range of industries, including software, robotics and AI, information services, e-commerce, consumer and online services, financial technology, digital publishing, among others. Chris has served on over 50 boards from early-stage companies to publicly traded businesses with multiple investments grown from seed stage to unicorn status.

Jack McCarthy, Managing Partner and Founder, Alvarez & Marsal Capital

Jack McCarthy is a Managing Partner and Founder of Alvarez & Marsal Capital. He is responsible for all aspects of A&M Capital’s business and sits on the Investment and Valuation Committees for all the firm’s investment strategies. Mr. McCarthy currently serves on the board of A&M Capital’s investments in BrightPet Nutrition, GS Foods, PetWise, The Arcticom Group, and VTG, and is a board observer at ProAmpac. Mr. McCarthy has over 30 years of experience private equity investing and operational experience. Before founding A&M Capital, he was a Managing Director, Founder and Co-National Practice Leader of Alvarez & Marsal’s Private Equity Advisory Group, which serves both private equity sponsors and select strategic investors. Prior to that, Mr. McCarthy was a Partner of BA Capital Partners Europe, Bank of America’s European focused middle-market private equity partnership. 

John Toomey, Chief Executive Officer, HarbourVest Partners

John Toomey is the Chief Executive Officer (CEO) of HarbourVest Partners and has served in that capacity since October 1, 2024. He is based at the Firm’s headquarters in Boston.

Prior to his appointment as CEO, John served on the Executive Management Committee (EMC), which led the firm, since 2012. He joined the firm in 1997 as an Analyst in the Direct team and spent ten years as one of the leaders of the Secondary business before serving on Global Investment Committees for nearly a decade. He was also involved in the 2007 IPO of HarbourVest Global Private Equity on Euronext Amsterdam for which he served as the original Chief Financial Officer.

John is a member of the Firm’s Portfolio Construction Committee, Conflicts Committee, ESG Council and DEI Council.

He received a BA (cum laude) in Chemistry and Physics from Harvard University in 1995 and an MBA from Harvard Business School in 2001, where he was awarded the Loeb Fellowship for outstanding achievement in finance.


PLATINUM SPONSORS

GOLD SPONSORS

SILVER SPONSORS

INDUSTRY PARTNERS

WI-FI SPONSOR

ENGAGEMENT APP SPONSOR

REQUEST AGENDA

Please note only corporate email addresses will be accepted.

Why do I need to enter my corporate email address?
By using your corporate email address, we can verify that you are a registered financial professional.

Key Discussion Topics

Panel Discussion: Investing in US Private Equity

With an uncertain overall outlook for pricing and opportunities, how can fund managers remain both informed and flexible about the state of the market? Leading fund managers discuss their investment thesis regarding investment strategies, favorable sectors, exits, and portfolio company management.



Panel Discussion: Investing in Private Equity Healthcare 

As investors took to resilient sectors capable of withstanding inflation and market contraction, healthcare has become a more attractive investment. From biopharma to medtech, diagnostics and healthcare IT, which subsectors are offering optimal returns? Experts discuss the most promising and challenging outlooks on healthcare investing.



Panel Discussion: Private Credit—Challenges, Risks, and Opportunities 

An allocation to credit can offer higher risk adjusted returns, boost diversification, and provide new income streams. In 2023, we saw a clear shift in the market as a result of the continuous increases in interest rates, which resulted in private credit activity skyrocketing. Join leading fund manager as they discuss lender dynamics, deal terms, market competitive[1]ness and their outlook on the asset class throughout 2024.



Panel Discussion: Middle Market & Growth Investing

In this crowded private market, where high valuations are slowing the investment pace, GPs have been forced to be more creative in finding value. Increasingly, in the middle market more firms are seeking growth equity investment opportunities rather than traditional leveraged buyouts. Hybrid, crossover and growth funds are on the rise. How are investors sourcing deals for  non-control investments? What challenges and opportunities lie ahead in the realm of growth investing for managers and institutional investors?



REGISTRATION

INVESTORS: Complimentary Registration for all qualified investors. Email [email protected] for more information on obtaining a complimentary ticket.

MANAGERS & SERVICE PROVIDERS: Rates below reflect the current price for all asset managers and service providers.

PRICING

Event Registration - Managers & Service Providers 5000 USD 11/07/24

VENUE


Mandarin Oriental, Boston
776 Boylston St
Boston, MA
United States 02199
CLICK TO VISIT VENUE WEBSITE

CONTACT

Sponsorship Opportunities & Registration

+1 212-804-6220

[email protected]

Allocator Attendance

+1 347-778-2568

[email protected]

Media Partnerships

+1 212-600-8631

[email protected]